159 related articles for article (PubMed ID: 204668)
1. The glucagonoma syndrome.
Shupack JL; Berczeller PH; Stevens DM
J Dermatol Surg Oncol; 1978 Mar; 4(3):242-7. PubMed ID: 204668
[TBL] [Abstract][Full Text] [Related]
2. Necrolytic migratory erythema. Distinctive dermatosis of the glucagonoma syndrome.
Kahan RS; Perez-Figaredo RA; Neimanis A
Arch Dermatol; 1977 Jun; 113(6):792-7. PubMed ID: 194537
[TBL] [Abstract][Full Text] [Related]
3. Glucagonoma syndrome. Report of two cases and literature review.
Binnick AN; Spencer SK; Dennison WL; Horton ES
Arch Dermatol; 1977 Jun; 113(6):749-54. PubMed ID: 194536
[TBL] [Abstract][Full Text] [Related]
4. The glucagonoma syndrome. A distinctive cutaneous marker of systemic disease.
Swenson KH; Amon RB; Hanifin JM
Arch Dermatol; 1978 Feb; 114(2):224-8. PubMed ID: 204256
[TBL] [Abstract][Full Text] [Related]
5. A glucagonoma syndrome.
Mallinson CN; Bloom SR; Warin AP; Salmon PR; Cox B
Lancet; 1974 Jul; 2(7871):1-5. PubMed ID: 4134714
[No Abstract] [Full Text] [Related]
6. Papulosquamous eruption with weight loss: Necrolytic migratory erythema (glucagonoma syndrome).
Skouge JW; Farmer ER
Arch Dermatol; 1985 Mar; 121(3):400, 403. PubMed ID: 2983618
[No Abstract] [Full Text] [Related]
7. Metabolic studies and glucagon gel filtration pattern before and after surgery in a case of glucagonoma syndrome.
von Schenck H; Thorell JI; Berg J; Bojs G; Dymling JF; Hallengren B; Ljungberg O; Tibblin S
Acta Med Scand; 1979; 205(3):155-62. PubMed ID: 218426
[TBL] [Abstract][Full Text] [Related]
8. Necrolytic migratory erythema and glucagon cell tumour of the pancreas: the glucagonoma syndrome. Report of two cases.
Pedersen NB; Jonsson L; Holst JJ
Acta Derm Venereol; 1976; 56(5):391-5. PubMed ID: 78626
[TBL] [Abstract][Full Text] [Related]
9. Necrolytic migratory erythema, presenting as candidiasis, due to a pancreatic glucagonoma.
Katz R; Fischmann AB; Galotto J; Guccio JG; Higgins GA; Ortega LG; West WH; Recant L
Cancer; 1979 Aug; 44(2):558-63. PubMed ID: 476569
[TBL] [Abstract][Full Text] [Related]
10. Glucagonoma syndrome: case report and literature review.
Parker CM; Hanke CW; Madura JA; Liss EC
J Dermatol Surg Oncol; 1984 Nov; 10(11):884-9. PubMed ID: 6092443
[TBL] [Abstract][Full Text] [Related]
11. Glucagonoma syndrome. A clinicopathologic, immunocytochemical, and ultrastructural study.
Vandersteen PR; Scheithauer BW
J Am Acad Dermatol; 1985 Jun; 12(6):1032-9. PubMed ID: 2989344
[TBL] [Abstract][Full Text] [Related]
12. The glucagonoma syndrome.
Lewis AE
Int J Dermatol; 1979; 18(1):17-22. PubMed ID: 216645
[TBL] [Abstract][Full Text] [Related]
13. The glucagonoma syndrome: surgically curable diabetes.
Higgins GA; Recant L; Fischman AB
Am J Surg; 1979 Jan; 137(1):142-8. PubMed ID: 215044
[No Abstract] [Full Text] [Related]
14. Demonstration of glucagon in islet cell adenomas of the pancreas by immunofluorescent technic.
Lomský R; Langr F; Vortel V
Am J Clin Pathol; 1969 Feb; 51(2):245-50. PubMed ID: 4304016
[No Abstract] [Full Text] [Related]
15. [Glucagonoma syndrome in a multihormonal pancreatic tumor].
Keller U; Fankhauser S; Schumacher A; Trimble ER; Heitz PU
Schweiz Med Wochenschr; 1982 Feb; 112(9):297-304. PubMed ID: 6281878
[TBL] [Abstract][Full Text] [Related]
16. Glucagonoma syndrome and necrolytic migratory erythema.
Lobo I; Carvalho A; Amaral C; Machado S; Carvalho R
Int J Dermatol; 2010 Jan; 49(1):24-9. PubMed ID: 20465606
[TBL] [Abstract][Full Text] [Related]
17. [Necrolytic migratory erythema: glucagonoma syndrome. Clinical and histological aspects].
Wilkinson DS
Ann Med Interne (Paris); 1984; 135(8):654-7. PubMed ID: 6099068
[TBL] [Abstract][Full Text] [Related]
18. Effect of somatostatin in necrolytic migratory erythema of glucagonoma.
Elsborg L; Glenthøj A
Acta Med Scand; 1985; 218(2):245-9. PubMed ID: 2865872
[TBL] [Abstract][Full Text] [Related]
19. Glucagonoma presenting as morbid obesity.
J Surg Oncol; ; . PubMed ID: 2848156
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
